United States · FDA National Drug Code directory

TRUQAP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0310-9500_d2081b19-6f23-454d-b426-2710d8319f23
Product NDC
0310-9500
Form
TABLET, FILM COATED
Composition / generic term
capivasertib
Labeler
AstraZeneca Pharmaceuticals LP
Marketing category
NDA
Marketing start / end (source format)
20231116
Source listing expiry
20271231

Source-listed ingredients

  • CAPIVASERTIB — 160 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 64 TABLET, FILM COATED in 1 BOTTLE (0310-9500-01) · 0310-9500-01
  • 4 BLISTER PACK in 1 CARTON (0310-9500-02) / 16 TABLET, FILM COATED in 1 BLISTER PACK · 0310-9500-02

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →